Nearly three-quarters of drug-related questions received no response or incomplete, wrong answers
Model Based on Age, Routine Lab Tests Predicts Atherosclerotic CVD Accurately
C-statistics for laboratory models do not differ significantly from those of more complex pooled cohort equations
Continuing Tirzepatide Leads to Maintenance of Weight Reduction
Continued tirzepatide treatment maintains and augments initial weight reduction seen in first 36 weeks
Changes in Cardiac Structure ID’d in Latinas With Hypertensive Disorders of Pregnancy
Alterations in cardiac structure and systolic and diastolic dysfunction partially mediated by current hypertension
White House Looks to Curb Big Pharma’s Sky-High Drug Prices
If a drug is too expensive, the Biden administration will use federal law to grant patent licenses to rival pharma companies
Smoking Outcomes Worse for Minority Adults Versus White Adults
Despite lower overall smoking rates, minority adults have higher smoking-related health care spending and chronic diseases
Biden Menthol Cigarette Ban Delayed Amid Political Pushback
The delay, which was posted Wednesday, now says officials plan to finalize rules to put the ban in place in March
Cardiovascular Benefits Seen With as Few as 2,600 Steps Daily
Additional mortality benefits were found at a moderate-to-high versus low step cadence
Earlier Age at Menarche Raises Type 2 Diabetes Risk
Additionally, among women with diabetes, earlier age at menarche tied to increased stroke risk
Eli Lilly Says Its New Weight-Loss Drug, Zepbound, Is Now Available
Tirzepatide, the active ingredient in Zepbound, had already been approved by the FDA as a treatment for type 2 diabetes